Provenance Wealth Advisors’s TriSalus Life Sciences TLSI Stock Holding History

Provenance Wealth Advisors’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$93.7K	Buy	+21,737	New	+$103K	0.01%	622

Other funds holding TLSI

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Connecticut Wealth Management Farmington, Connecticut $2.73B AUM 14.39% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

SJS Investment Consulting Sylvania, Ohio $993M AUM 16.29% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Provenance Wealth Advisors's TLSI Position: Q3 2026 in Review

Provenance Wealth Advisors opened a new position in TriSalus Life Sciences (TLSI) in Q3 2026: 21,737 shares worth $93.7K. The stake represents 0.01% of the portfolio and ranks #622 among its holdings.

17 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

Provenance Wealth Advisors held 21,737 shares of TriSalus Life Sciences worth $93.7K as of Q3 2026.
TriSalus Life Sciences was a new Provenance Wealth Advisors position in Q3 2026.
TriSalus Life Sciences made up 0.01% of Provenance Wealth Advisors's portfolio in Q3 2026, its #622 holding.
17 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on Provenance Wealth Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.